Novo Nordisk’s GLP-1 pill gets EU approval for cardiovascular benefits

Novo Nordisk rose in early trading after it announced that European regulators approved its diabetes pill to be marketed for cardiovascular benefits as well.

Rybelsus — a pill version of semaglutide, the active ingredient in Ozempic and Wegovy — will now list cardiovascular benefits on its label in the European Union. In the US, the Food and Drug Administration is expected to decide on adding the cardiovascular indication for Rybelsus later this year.

Wegovy, Novo’s blockbuster weight-loss shot, is approved to treat cardiovascular conditions in the US and EU. Expanding the conditions Novo’s drugs can be prescribed for could help the Danish pharmaceutical giant spark growth as it faces pressure from Eli Lilly’s competitor drugs.

More Markets

See all Markets

Matt Phillips

Coinbase posts better-than-expected sales, profit, and transaction numbers

The crypto exchange rose slightly in early after-hours trading.

Western Digital jumps as Q1 sales and earnings beat, guidance better than expected, and dividend hiked

A litany of stellar news from the disk drive seller.

Matt Phillips3h

Max Knoblauch3h

Netflix rises on announcement of its 10-for-1 stock split

Netflix’s subscription prices keep rising, but its shares are about to get a bit cheaper.

On Thursday, the streamer announced it’ll perform a 10-for-1 forward stock split. On November 17, traders who own a single Netflix share will own 10 shares, though the company’s underlying value will remain the same.

Netflix shares have surged about 270% over the past three years to $1,089 as of today’s close, as the streamer has captured more of the streaming market share. The stock rose roughly 3% in after-hours trading on Thursday following the announcement.

Reddit rises in after-hours trading on Q3 earnings numbers

Here’s how they look.

Matt Phillips3h

Amazon soars as Q3 earnings, sales beat Wall Street expectations

Amazon released earnings on Thursday.

Jon Keegan4h

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.